Day One Biopharmaceuticals Stock Jumps on Renewed M&A Rumors
Day One Biopharmaceuticals shares surge 26% to $12.62 amid fresh speculation of a potential buyout.
Already have an account? Sign in.
Day One Biopharmaceuticals shares surge 26% to $12.62 amid fresh speculation of a potential buyout.
U.S. Justice Department probes Nutrien, Mosaic, CF Industries, Koch & Yara over potential antitrust violations driving up fertilizer prices for farmers. Early-stage inquiry highlights market concentration concerns.
CoreWeave announces multi-year deal to power Perplexity's AI inference on NVIDIA GB200 clusters.
Abercrombie & Fitch issued a cautious 2026 outlook, projecting 3–5% sales growth after factoring in the full 15% U.S. tariffs. Shares fell 5% in premarket trading.